Navigation Links
U of A's David Schindler confirms untold levels of oil sands pollution on the Athabasca
Date:12/7/2009

After an exhaustive study of air and water pollution along the Athabasca River and its tributaries from Fort McMurray to Lake Athabasca, researchers say pollution levels have increased as a direct result of nearby oil sands operations.

University of Alberta biological sciences professor David Schindler was part of the team that conducted a long term air and water study and found high levels of Polycyclic Aromatic Compounds. PACs are a group of organic contaminants containing several known carcinogens, mutagens, and teratogens. The highest levels of PAC's were found within 50 kilometres of two major oil sands up graders.

Schindler says that government and industry have claimed the pollution is a naturally occurring seepage from the oil sands deposits and are not related to the oil sands industry.

The research team monitored water and snow packs concentrations of pollutants along the Athabasca in winter and summer of 2008. Schindler and the others report that levels of PACs increased the closer they got to the oil sands developments and reached a point where the airborne particulates left oil slicks on top of melted snow.

"We found PACs in parts per trillion but they are toxic at parts per trillion," said Schindler.

The new study took measurements at 60 locations along the Athabasca and its tributaries. Schindler says that currently the Federal Government operates one water quality collection point in the area.


'/>"/>

Contact: Brian Murphy
brian.murphy@ualberta.ca
780-492-6041
University of Alberta
Source:Eurekalert

Page: 1

Related biology news :

1. David H. Ledbetter, PhD, FACMG is the 2008-2009 Luminex/ACMGF Award recipient
2. Prof. David Kisailus studies engineering and invention on the half-shell
3. Al Gore and Tom Stoppard among 2008 Dan David Prize Winners at TAU
4. American Society for Microbiology honors David J. Lipman
5. Sir David Lane honored with Royal Gold Medal by Royal Society of Edinburgh
6. David Salt is worth his salt, says Science magazine
7. Protein folding researcher David Baker to receive Sackler Prize in Biophysics
8. David Rose to present Howe School lecture on new technologies and business models, Jan. 29
9. American Society for Microbiology honors David Masopust for research on T cell memory
10. Adult brain can change, study confirms
11. Avian origins: new analysis confirms ancient beginnings
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/9/2017)... , March 9, 2017 4Dx has publicly ... Lung Imaging Workshop at the University of Pennsylvania. Founder ... to deliver the latest data to world leaders in ... brings together leaders at the forefront of the industry ... imaging. "The quality of the imaging ...
(Date:3/2/2017)... , March 2, 2017 Summary ... understand Perrigo and its partnering interests and activities since 2010. ... Read ... Deals and Alliance since 2010 report provides an in-depth insight ... life sciences companies. On demand company reports are ...
(Date:2/28/2017)... , Feb. 28, 2017   Acuant , ... software globally, announces significant enhancements to new and core ... 2016. New products include mobile and desktop Acuant FRM ... TM - a real time manual review of ... idScan® technology provides the fastest and most accurate capture ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... , March 23, 2017  SeraCare ... to global in vitro diagnostics manufacturers and ... the industry,s first multiplexed Inherited Cancer ... testing by next-generation sequencing (NGS). The Seraseq™ ... developed with input from industry experts to ...
(Date:3/23/2017)... -- Kineta, Inc., a biotechnology company focused on ... today announced the discovery and characterization of several ... interferon response factor 3 (IRF3) via RIG-I like ... in a murine colon carcinoma mouse model.  Furthermore, ... regression to initial drug treatment were resistant to ...
(Date:3/23/2017)... -- In today,s pre-market research, Stock-Callers.com takes ... industry: Sangamo Therapeutics Inc. (NASDAQ: SGMO), Eyegate Pharmaceuticals Inc. ... Regulus Therapeutics Inc. (NASDAQ: RGLS ). On ... rating on Pharmaceuticals/Biotechnology to "Overweight" from "Market Weight." Learn more about ... ...
(Date:3/22/2017)... March 22, 2017  Ascendis Pharma A/S (Nasdaq: ... TransCon technology to address significant unmet medical needs ... the full year ended December 31, 2016. ... our company as we broadened our pipeline and ... rare disease company with an initial focus on ...
Breaking Biology Technology: